XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Bentley Systems Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021     282,526,719        
Beginning balance at Dec. 31, 2021 $ 409,222 $ 409,222 $ 2,825 $ 937,805 $ (91,774) $ (439,634) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 174,780 174,780       174,780  
Other comprehensive income (loss) 2,034 2,034     2,034    
Dividends declared (34,353) (34,353)       (34,353)  
Shares issued in connection with DCP, net (in shares)     3,541,375        
Shares issued in connection with DCP, net (24,246) (24,246) $ 35 (27)   (24,254)  
DCP elective participant deferrals 6,580 6,580   6,580      
Shares issued in connection with Bonus Plan, net (in shares)     445,050        
Shares issued in connection with Bonus Plan, net 16,728 16,728 $ 5 21,920   (5,197)  
Shares issued in connection with employee stock purchase plan, net (in shares)     307,406        
Shares issued in connection with employee stock purchase plan, net 10,062 10,062 $ 3 10,332   (273)  
Stock option exercises, net (in shares)     2,613,659        
Stock option exercises, net (850) (850) $ 26 8,312   (9,188)  
Acquisition option exercises, net (in shares)     185,178        
Acquisition option exercises, net 0 0 $ 2 (2)      
Shares issued for stock grants, net (in shares)     13,632        
Shares issued for stock grants, net 450 450   450      
Stock-based compensation expense 45,100 45,100   45,100      
Shares related to restricted stock, net (in shares)     277,594        
Shares related to restricted stock, net (4,492) (4,492) $ 3 (4)   (4,491)  
Repurchases of Class B common stock under approved program (in shares)     (896,126)        
Repurchases of Class B common stock under approved program (28,250) (28,250) $ (9)     (28,241)  
Other (15) (15)       (15)  
Noncontrolling interest acquired 704 0         704
Ending balance (in shares) at Dec. 31, 2022     289,014,487        
Ending balance at Dec. 31, 2022 573,454 572,750 $ 2,890 1,030,466 (89,740) (370,866) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 326,787 326,787       326,787  
Other comprehensive income (loss) 4,753 4,753     4,753    
Dividends declared (58,756) (58,756)       (58,756)  
Shares issued in connection with DCP, net (in shares)     3,410,006        
Shares issued in connection with DCP, net (38,456) (38,456) $ 34 (34)   (38,456)  
DCP elective participant deferrals 1,765 1,765   1,765      
Shares issued in connection with Bonus Plan, net (in shares)     247,867        
Shares issued in connection with Bonus Plan, net 11,035 11,035 $ 3 16,788   (5,756)  
Shares issued in connection with employee stock purchase plan, net (in shares)     315,840        
Shares issued in connection with employee stock purchase plan, net 9,143 9,143 $ 3 9,985   (845)  
Stock option exercises, net (in shares)     2,621,959        
Stock option exercises, net 5,134 5,134 $ 26 11,689   (6,581)  
Shares issued for stock grants, net (in shares)     12,639        
Shares issued for stock grants, net 600 600   600      
Stock-based compensation expense 55,982 55,982   55,982      
Shares related to restricted stock, net (in shares)     643,039        
Shares related to restricted stock, net (7,299) (7,299) $ 7 (7)   (7,299)  
Other (160) (160)       (160)  
Ending balance (in shares) at Dec. 31, 2023     296,265,837        
Ending balance at Dec. 31, 2023 883,982 883,278 $ 2,963 1,127,234 (84,987) (161,932) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 234,433 234,787       234,787 (354)
Other comprehensive income (loss) (19,133) (19,091)     (19,091)   (42)
Dividends declared (72,115) (72,115)       (72,115)  
Shares issued in connection with DCP, net (in shares)     4,707,845        
Shares issued in connection with DCP, net 0 0 $ 47 (47)      
DCP elective participant deferrals 188 188   188      
Shares issued in connection with Bonus Plan, net (in shares)     282,340        
Shares issued in connection with Bonus Plan, net 14,476 14,476 $ 3 14,473      
Shares issued in connection with employee stock purchase plan, net (in shares)     253,578        
Shares issued in connection with employee stock purchase plan, net 10,880 10,880 $ 2 11,226   (348)  
Stock option exercises, net (in shares)     844,283        
Stock option exercises, net 1,812 1,812 $ 8 3,999   (2,195)  
Shares issued for stock grants, net (in shares)     11,391        
Shares issued for stock grants, net 600 600   600      
Stock-based compensation expense 60,322 60,322   60,322      
Shares related to restricted stock, net (in shares)     904,789        
Shares related to restricted stock, net (9,966) (9,966) $ 9 (9)   (9,966)  
Repurchases of Class B common stock under approved program (in shares)     (1,292,733)        
Repurchases of Class B common stock under approved program (64,359) (64,359) $ (12)     (64,347)  
Other 0 175       175 (175)
Ending balance (in shares) at Dec. 31, 2024     301,977,330        
Ending balance at Dec. 31, 2024 $ 1,041,120 $ 1,040,987 $ 3,020 $ 1,217,986 $ (104,078) $ (75,941) $ 133